Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veritas Genetics is a pioneer in the consumer genomics space, famously known for being the first company to offer whole genome sequencing (WGS) and interpretation for under $1,000. Founded by leaders in personal genomics from Harvard Medical School, the company provides comprehensive genetic testing services that include screening for disease risks, carrier status, and pharmacogenomic profiles. Their flagship product, myGenome, utilizes a proprietary platform to provide actionable health insights to individuals and their physicians. In 2022, the company was acquired by LetsGetChecked to integrate advanced genomic data into a broader home-based healthcare and diagnostic ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veritas.